{"id":"https://openalex.org/W2017600509","doi":"https://doi.org/10.1097/01.qai.0000230318.40170.60","title":"An Adenovirus-Based HIV Subtype B Prime/Boost Vaccine Regimen Elicits Antibodies Mediating Broad Antibody-Dependent Cellular Cytotoxicity Against Non-Subtype B HIV Strains","display_name":"An Adenovirus-Based HIV Subtype B Prime/Boost Vaccine Regimen Elicits Antibodies Mediating Broad Antibody-Dependent Cellular Cytotoxicity Against Non-Subtype B HIV Strains","publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2017600509","doi":"https://doi.org/10.1097/01.qai.0000230318.40170.60","mag":"2017600509","pmid":"https://pubmed.ncbi.nlm.nih.gov/16940858"},"language":"en","primary_location":{"id":"doi:10.1097/01.qai.0000230318.40170.60","doi":"https://doi.org/10.1097/01.qai.0000230318.40170.60","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000230318.40170.60","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"V. Ra??l G??mez-Rom??n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"V. Ra??l G??mez-Rom??n","raw_affiliation_strings":["Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5065, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091030939","display_name":"Ruth H. Florese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ruth H Florese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076709492","display_name":"Bo Peng","orcid":"https://orcid.org/0000-0003-4482-2885","observed_orcids":["https://orcid.org/0000-0003-4482-2885","https://orcid.org/0009-0007-3340-4318"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Bo Peng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004036928","display_name":"David C. Montefiori","orcid":"https://orcid.org/0000-0003-0856-6319","observed_orcids":["https://orcid.org/0000-0003-0856-6319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David C Montefiori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111650976","display_name":"Vaniambadi S. Kalyanaraman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vaniambadi S Kalyanaraman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024024043","display_name":"David J. Venzon","orcid":"https://orcid.org/0000-0002-8990-158X","observed_orcids":["https://orcid.org/0000-0002-8990-158X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Venzon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112501357","display_name":"Indresh K. Srivastava","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Indresh Srivastava","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073120779","display_name":"Susan W. Barnett","orcid":"https://orcid.org/0000-0003-4586-1018","observed_orcids":["https://orcid.org/0000-0003-4586-1018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan W Barnett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5067964875","display_name":"Marjorie Robert-Guroff","orcid":"https://orcid.org/0000-0003-0606-6636","observed_orcids":["https://orcid.org/0000-0003-0606-6636"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marjorie Robert-Guroff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5067964875","https://openalex.org/A5076709492","https://openalex.org/A5091030939"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"],"apc_list":null,"apc_paid":null,"fwci":2.1952,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.8688315,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"43","issue":"3","first_page":"270","last_page":"277"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-vaccine","display_name":"HIV vaccine","score":0.7360000014305115},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.8059999942779541},{"id":"https://openalex.org/keywords/hiv-subtype-b","display_name":"HIV subtype B","score":0.9359999895095825},{"id":"https://openalex.org/keywords/hiv-subtype-c","display_name":"HIV subtype C","score":0.7089999914169312},{"id":"https://openalex.org/keywords/hiv-1-crf01-ae","display_name":"CRF01_AE","score":0.9279999732971191},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/gp120","display_name":"gp120","score":0.7360000014305115},{"id":"https://openalex.org/keywords/hiv-envelope-protein","display_name":"HIV envelope protein","score":0.6169999837875366},{"id":"https://openalex.org/keywords/prime-boost-regimen","display_name":"prime-boost regimen","score":0.6800000071525574},{"id":"https://openalex.org/keywords/chimpanzees","display_name":"chimpanzees","score":0.6349999904632568},{"id":"https://openalex.org/keywords/mf59-adjuvant","display_name":"MF59 adjuvant","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.9260901808738708},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.8062981367111206},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7017000913619995},{"id":"https://openalex.org/C2780115692","wikidata":"https://www.wikidata.org/wiki/Q5747302","display_name":"Heterologous","level":3,"score":0.6631412506103516},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6549645662307739},{"id":"https://openalex.org/C2780195530","wikidata":"https://www.wikidata.org/wiki/Q1479804","display_name":"HIV vaccine","level":4,"score":0.5311316847801208},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4977302849292755},{"id":"https://openalex.org/C2909828532","wikidata":"https://www.wikidata.org/wiki/Q1479804","display_name":"AIDS Vaccines","level":4,"score":0.45958012342453003},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.41595980525016785},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3255695700645447},{"id":"https://openalex.org/C2778190748","wikidata":"https://www.wikidata.org/wiki/Q7907956","display_name":"Vaccine trial","level":3,"score":0.29576578736305237},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.29370492696762085},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.2427918016910553},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.19220629334449768},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.1401752233505249},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0757884681224823}],"mesh":[{"descriptor_ui":"D000256","descriptor_name":"Adenoviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002679","descriptor_name":"Pan troglodytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007117","descriptor_name":"Immunization, Secondary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009500","descriptor_name":"Neutralization Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014765","descriptor_name":"Viral Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.qai.0000230318.40170.60","doi":"https://doi.org/10.1097/01.qai.0000230318.40170.60","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.qai.0000230318.40170.60","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:16940858","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16940858","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8399999737739563,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3950345252","display_name":null,"funder_award_id":"P01 AI48225-03","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G8467230203","display_name":"Multi-component HIV Vaccines Using Engineered Envelopes","funder_award_id":"P01AI048225","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W171142067","https://openalex.org/W1487204939","https://openalex.org/W1528520360","https://openalex.org/W1529373421","https://openalex.org/W1584836554","https://openalex.org/W1594804329","https://openalex.org/W1949254894","https://openalex.org/W1968648567","https://openalex.org/W1974716123","https://openalex.org/W1987971591","https://openalex.org/W1994646934","https://openalex.org/W2006552334","https://openalex.org/W2023765040","https://openalex.org/W2035070408","https://openalex.org/W2036166112","https://openalex.org/W2042308547","https://openalex.org/W2042741316","https://openalex.org/W2051108441","https://openalex.org/W2065596070","https://openalex.org/W2066037887","https://openalex.org/W2070786732","https://openalex.org/W2084437187","https://openalex.org/W2085988761","https://openalex.org/W2099067260","https://openalex.org/W2102084617","https://openalex.org/W2103347074","https://openalex.org/W2110287237","https://openalex.org/W2110945669","https://openalex.org/W2111759310","https://openalex.org/W2117522423","https://openalex.org/W2123602858","https://openalex.org/W2127682720","https://openalex.org/W2128265486","https://openalex.org/W2129793752","https://openalex.org/W2141813702","https://openalex.org/W2141866540","https://openalex.org/W2144687970","https://openalex.org/W2159035586","https://openalex.org/W2160056486","https://openalex.org/W2170170182","https://openalex.org/W2177434887","https://openalex.org/W2409720954"],"related_works":["https://openalex.org/W2515855649","https://openalex.org/W2171139716","https://openalex.org/W2128265486","https://openalex.org/W2141813702","https://openalex.org/W2144563230","https://openalex.org/W2770378131","https://openalex.org/W2497843697","https://openalex.org/W2074401584","https://openalex.org/W2046782578","https://openalex.org/W2083854857"],"abstract_inverted_index":{"Although":[0],"HIV":[1,12,29,73,85,137,151,178,204],"subtype":[2,86,106,116,152,159],"B":[3,160,183,203],"predominates":[4],"in":[5,58,189],"North":[6],"America":[7],"and":[8,45,48,67,78,90,119,140,154,186],"Western":[9],"Europe,":[10],"most":[11],"infections":[13],"worldwide":[14],"are":[15],"non-subtype":[16,182,202],"B.":[17,141],"Globally":[18],"effective":[19],"AIDS":[20],"vaccines":[21],"need":[22],"to":[23,196],"elicit":[24,197],"broad":[25,173],"immunity":[26],"against":[27,72,114,150,176,201],"multiple":[28],"strains.":[30,205],"In":[31],"this":[32],"study,":[33],"10":[34,98,144],"chimpanzees":[35,100],"were":[36,62],"intranasally":[37],"primed":[38],"sequentially":[39],"with":[40,52,134],"adenovirus":[41],"type":[42],"5":[43],"(Ad5)-":[44],"Ad7-HIVMNenv/rev":[46],"recombinants":[47],"boosted":[49],"twice":[50],"intramuscularly":[51],"heterologous":[53,103],"oligomeric":[54],"HIVSF162":[55],"gp140DeltaV2":[56],"protein":[57,164,187],"MF59":[59],"adjuvant.":[60],"Sera":[61,94,125],"evaluated":[63],"for":[64,171],"binding,":[65],"neutralizing,":[66],"antibody-dependent":[68],"cellular":[69],"cytotoxicity":[70],"(ADCC)":[71],"clades":[74],"A,":[75,87,117],"B,":[76,88],"C,":[77],"CRF01_AE.":[79],"The":[80],"vaccine":[81],"regimen":[82,166],"elicited":[83],"high-titered":[84],"C":[89,107,118,153],"CRF01_AE":[91,155],"gp120-binding":[92],"antibodies.":[93],"from":[95,126,136],"7":[96],"of":[97,131,143],"vaccinated":[99],"cross-neutralized":[101],"the":[102],"South":[104],"African":[105],"primary":[108],"HIVTV-1":[109],"isolate.":[110],"Significant":[111],"cross-clade":[112],"neutralization":[113],"other":[115],"E":[120],"isolates":[121],"was":[122],"not":[123],"observed.":[124],"all":[127],"animals":[128,145],"mediated":[129],"ADCC":[130,148,174],"cells":[132],"coated":[133],"gp120":[135],"subtypes":[138],"A":[139],"Nine":[142],"also":[146],"exhibited":[147],"activity":[149,175],"gp120-coated":[156],"targets.":[157],"This":[158],"Ad-HIV":[161],"recombinant":[162],"prime/envelope":[163],"boost":[165],"is":[167],"a":[168,190],"promising":[169],"approach":[170],"eliciting":[172],"diverse":[177],"clades.":[179],"Incorporating":[180],"additional":[181],"envelope":[184],"genes":[185],"boosts":[188],"multivalent":[191],"strategy":[192],"may":[193],"be":[194],"required":[195],"broader":[198],"neutralizing":[199],"antibodies":[200]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}